Bristol-Myers Squibb(BMY) Seeking Alpha·2025-06-11 17:43Core Insights - Bristol-Myers Squibb Company participated in the Goldman Sachs 46th Annual Global Healthcare Conference, highlighting its engagement with the pharmaceutical sector and the current operating environment [1][4]. Group 1: Company Overview - Christopher S. Boerner serves as the CEO and Chairman of Bristol-Myers Squibb, while Adam Lenkowsky is the Chief Commercialization Officer [1][2][3]. - The company is actively engaging with the U.S. administration regarding policy-related uncertainties affecting the pharmaceutical industry [4][5]. Group 2: Industry Context - The pharmaceutical sector is currently facing external operating environment challenges, including policy-related uncertainties that have been a topic of discussion among various companies at the conference [4]. - Conversations with the administration are reportedly moving in a positive direction, although the outcomes remain uncertain [4].